Patents
Patents for C07D 517 - Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms (452)
10/2003
10/01/2003CN1122670C Thiazolobenzoheterocycles, prepn method and medicines containing same
09/2003
09/30/2003US6627640 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
09/30/2003US6627638 Viricides, anticarcinogneic agents
09/24/2003EP1100802B1 OXAZOLO, THIAZOLO AND SELENAZOLO [4,5-c]-QUINOLINE-4-AMINES AND ANALOGS THEREOF
09/17/2003EP1027359B9 Monocyclic l-nucleosides, analogs and uses thereof
07/2003
07/09/2003EP0948500B1 Cyclic organoselenium compounds, their preparation and their uses
07/01/2003US6586418 Heteroaryl-phenyl substituted compounds that are inhibitors of trypsin-like serine protease enzymes; anticoagulant for treatment and prevention of thromboembolic disorders
06/2003
06/05/2003US20030105130 Thiaporphyrin, selenaporphyrin, and carotenoid porphyrin compounds as c-myc and telomerase inhibitors
06/04/2003EP0783507B1 Compounds useful as antiproliferative agents and garft inhibitors
06/03/2003US6573248 Monocyclic L-nucleosides, analogs and uses thereof
04/2003
04/23/2003EP1027359B1 Monocyclic l-nucleosides, analogs and uses thereof
04/22/2003US6552183 Moncyclic L-nucleosides analogs
04/10/2003US20030069219 Core modified porphyrins
04/03/2003US20030065006 Viricides; anticancer agents
04/03/2003US20030064968 Viricides, anticarcinogneic agents
03/2003
03/26/2003EP1294684A2 THROMBIN OR FACTOR Xa INHIBITORS
03/20/2003US20030055031 As anticonvulsants; for therapy and prophylaxis of ischaemias, anoxia, neurodegenerative diseases
03/06/2003US20030045545 Immunomodulators, induce cytokine biosynthesis, and antineoplastic agents
02/2003
02/25/2003US6525040 4,4-dimethyl-thieno-(3,2-e)-isoselenazine; antioxidants and cytoprotecting
02/13/2003WO2003011286A1 Core modified porphyrins
02/06/2003WO2003010154A1 Seleno compounds containing nitrone moiety, their preparation and their therapeutic uses
01/2003
01/28/2003US6511681 Solubility and bioavailability of azole antifungal medicaments
01/23/2003US20030018186 Monocyclic L-nucleosides, analogs and uses thereof
01/08/2003EP1272900A2 High speed photothermographic materials containing tellurium compounds and methods of using same
12/2002
12/24/2002US6497905 Aqueous solubility pharmaceutical formulations
11/2002
11/13/2002CN1379768A Improved aqueous solubility pharmaceutical formulations
11/07/2002US20020164549 Tellurium chemical sensitizers added to the photothermographic emulsion, for example tellurium complexed with four imidazolidin-2-thione groups and two chlorine atoms
10/2002
10/30/2002CN1093541C Metalloporphyrin and producing process thereof
10/23/2002EP1000067B1 Thiazolobenzoheterocycles, preparation and medicines containing same
10/17/2002WO2002067053A3 High speed photothermographic materials containing tellurium compounds and methods of using same
10/10/2002WO2002078695A1 Thiaporphyrin, selenaporphyrin, and carotenoid porphyrin compounds as c-myc and telomerase inhibitors
09/2002
09/11/2002EP0763036B1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF
09/10/2002US6448241 Thiazolobenzoheterocycles, their preparation and medicaments containing them
08/2002
08/29/2002WO2002067053A2 High speed photothermographic materials containing tellurium compounds and methods of using same
08/27/2002US6440992 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
07/2002
07/25/2002WO2002002519A3 THROMBIN OR FACTOR Xa INHIBITORS
07/24/2002EP0966473B1 Thiazolobenzoheterocycles, preparation and medicines containing same
07/23/2002US6423715 Thiazolobenzoheterocycles, their preparation and medicaments containing them
07/18/2002US20020095033 Monocyclic L-nucleosides, analogs and uses thereof
06/2002
06/13/2002US20020072528 Are immunomodulators and induce cytokine biosynthesis, including interferon and/or tumor biosynthesis, necrosis factor, and inhibit T-helper-type 2 immune response; useful for therapy of viral and neoplastic diseases
04/2002
04/30/2002US6379707 Solid solution of amorphous pharmaceutically active agent, pharmaceutically acceptable hydrophobic vehicle, stabilizer, disintegrant; shelf life
04/09/2002US6369221 Anticonvulsants, antiischemic agents; brain and nervous system disorder treatment
04/09/2002CA2120229C Methylpiperazinoazepine derivatives, their preparation and their use
03/2002
03/28/2002US20020037324 Aqueous solubility pharmaceutical formulations
02/2002
02/21/2002US20020022614 Thrombin or factor Xa inhibitors
01/2002
01/31/2002US20020012706 Method of making granular pharmaceutical vehicle
01/10/2002WO2002002519A2 THROMBIN OR FACTOR Xa INHIBITORS
01/10/2002CA2413241A1 Thrombin or factor xa inhibitors
01/08/2002US6337395 Selenium derivatives of porphryn
12/2001
12/19/2001EP1163234A1 Improved aqueous solubility pharmaceutical formulations
11/2001
11/27/2001US6323200 The compounds are immunomodulators and induce cytokine biosynthesis, including interferon and/or tumor biosynthesis, necrosis factor, and inhibit the t-helper-type 2 immune response.
10/2001
10/31/2001CN1320126A Oxazolo, thiazolo and selenazolo [4,5-C]-quinolin-4-amines and analoges thereof
09/2001
09/11/2001US6288075 Antiepileptic agents; nervous system, brain, and cardiovascular disorders
06/2001
06/06/2001EP0681584B1 Condensed heterocyclic glutamic acid derivatives as antiproliferative agents
05/2001
05/23/2001EP1100802A1 OXAZOLO, THIAZOLO AND SELENAZOLO [4,5-c]-QUINOLIN-4-AMINES AND ANALOGS THEREOF
05/23/2001EP1100504A2 Pharmaceutical compositions and their uses for treatment of demyelinating disorders
04/2001
04/25/2001EP1094066A2 Condensed heterocyclic glutamic acid derivatives as antiproliferative agents
03/2001
03/22/2001WO2000001376A3 Pharmaceutical compositions and their uses for treatment of demyelinating disorders
03/06/2001US6197922 Polyselenophenes, the preparation thereof and the use thereof
10/2000
10/10/2000US6130326 L-ribavirin. oh; anticarcinogenic/antitumor agents; viricides; fungicides; treatment of autoimmune diseases
09/2000
09/28/2000WO2000056726A1 Improved aqueous solubility pharmaceutical formulations
09/27/2000CN1268140A Monocyclic L-nucleosides, analogs and uses thereof
08/2000
08/30/2000CN1265109A Thiazolobenzoheterocycles, prepn. and medicines containing same
08/29/2000US6110929 Immunomodulators which induce cytokine biosynthesis, including interferon and/or tumor biosynthesis, necrosis factor and inhibit t-helper-type 2 immune response; for treatment of viral and neoplastic diseases
08/16/2000EP1027359A2 Monocyclic l-nucleosides, analogs and uses thereof
07/2000
07/12/2000EP1017700A1 Macrocyclic porphyrazine-type compounds, metal derivatives thereof and process for their preparation
07/12/2000EP0698608B1 Spiropyran compound
06/2000
06/14/2000CN1053448C Compound useful as antiproliferative agents and GARFT inhibitors
05/2000
05/17/2000EP1000067A1 Thiazolobenzoheterocycles, preparation and medicines containing same
03/2000
03/21/2000US6040328 Aromatic diselenides and selenosulfides, their preparation and their uses, more particularly their therapeutical use
02/2000
02/15/2000CA2054701C Benzoselenazolino-vinylspiropyran compound and polymers containing the compound
02/10/2000WO2000006577A1 OXAZOLO, THIAZOLO AND SELENAZOLO [4,5-c]-QUINOLIN-4-AMINES AND ANALOGS THEREOF
01/2000
01/13/2000WO2000001376A2 Pharmaceutical compositions and their uses for treatment of demyelinating disorders
12/1999
12/29/1999EP0966473A1 Thiazolobenzoheterocycles, preparation and medicines containing same
11/1999
11/10/1999CN1046285C Condensed heterocyclic glutamic acid derivatives as antiproliferative agents
11/10/1999CN1046284C Spiro (dihydro indole) oxazine photochromic compounds
10/1999
10/26/1999US5973009 Antioxidant and cytoprotecting activity
10/13/1999EP0948500A1 Cyclic organoselenium compounds, their preparation and their uses
09/1999
09/28/1999US5958943 A!-anellated pyrrole derivatives and their use in pharmacology
08/1999
08/17/1999CA2028777C Spiropyran compounds
08/10/1999US5936070 Spiro-acridine dyes
07/1999
07/28/1999CN1224017A Metalloporphyrin and producing process thereof
04/1999
04/27/1999CA2051394C Macromolecular spiropyran compounds
04/01/1999WO1999015533A1 Macrocyclic porphyrazine-type compounds, metal derivatives thereof and process for their preparation
03/1999
03/17/1999EP0902043A2 Polyselenophenes, process for their preparation, and their use
02/1999
02/16/1999US5871670 Crosslinked polymer interpenetrated with network of crystal needles of charge transfer complex; plates, electrodes, pipes, bags
02/04/1999WO1999005147A1 Thiazolobenzoheterocycles, preparation and medicines containing same
11/1998
11/10/1998US5833885 Photochromic compounds
09/1998
09/03/1998WO1998038194A1 Thiazolobenzoheterocycles, preparation and medicines containing same
07/1998
07/09/1998WO1998029417A1 Cyclic organoselenium compounds, their preparation and their uses
07/09/1998CA2274909A1 Cyclic organoselenium compounds, their preparation and their uses
07/01/1998EP0850924A1 Aromatic diselenides and selenosulphides for use as antioxidant agents
06/1998
06/11/1998WO1998016186A3 Monocyclic l-nucleosides, analogs and uses thereof
04/1998
04/23/1998WO1998016186A2 Monocyclic l-nucleosides, analogs and uses thereof
04/23/1998CA2267279A1 Monocyclic l-nucleosides, analogs and uses thereof
03/1998
03/03/1998US5723607 Chemical intermediates, enzyme inhibitors, antitumor agents, antigrowth agents
01/1998
01/13/1998US5708181 Spiropyran compound
10/1997
10/02/1997DE19700146A1 Fragmented fullerene cage molecules used for e.g. biomedical applications, fire quenching, explosives or fuels
09/1997
09/30/1997US5672478 Methods of use for and kits containing chemiluminescent compounds
09/16/1997US5667764 Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles
1 2 3 4 5